APO RESEARCH · REPORT
Taurine
Taurine is an organic acid widely distributed in animal tissues, and also exist in human beings’ body. But cats cannot produce taurine by itself.
Product & engineering
Understand the product.
Taurine is an organic acid widely distributed in animal tissues, and also exist in human beings’ body. But cats cannot produce taurine by itself.
Selected research
Industry Research
Taurine Industry Research Report 2026
Market perspective
Taurine is an organic acid widely distributed in animal tissues, and also exist in human beings’ body. But cats cannot produce taurine by itself.
Global Taurine key players include Yongan Pharmaceutical, Grand Pharma, Jiangyin Huachang, etc. Global top three manufacturers hold a share over 85%.
Asia-Pacific is the largest market, with a share over 30%, followed by Europe, and North America, both have a share over 55 percent.
Read the full market overview
In terms of product, Ethylene Oxide Method is the largest segment, with a share over 85%. And in terms of application, the largest application is Beverage, followed by Pet Food, Healthcare Products, etc.
Report Scope
This report quantifies the global Taurine market in terms of revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Taurine Market by Company
Yongan Pharmaceutical
Grand Pharma
Jiangyin Huachang
Yuanyang Pharmaceutical
Taisho Pharmaceutical
Taurine Segment by Technology
Ethylene Oxide Method
Ethanol Amine Method
Taurine Segment by Application
Beverage
Pet Food
Health Care Products
Others
Taurine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taurine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Taurine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taurine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Taurine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Taurine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Taurine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by technology, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ethylene Oxide Method
- Ethanol Amine Method
Applications
- Beverage
- Pet Food
- Health Care Products
- Others
Companies covered
- Yongan Pharmaceutical
- Grand Pharma
- Jiangyin Huachang
- Yuanyang Pharmaceutical
- Taisho Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Taurine Market Size (2021-2032)
- 2.2.2 Global Taurine Sales (2021-2032)
- 2.2.3 Global Taurine Market Average Price (2021-2032)
- 2.3 Taurine by Technology
- 2.3.1 Market Value Comparison by Technology (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Ethylene Oxide Method
- 2.3.3 Ethanol Amine Method
- 2.4 Taurine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Beverage
- 2.4.3 Pet Food
- 2.4.4 Health Care Products
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Taurine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Taurine Sales (MT) of Manufacturers (2021-2026)
- 3.3 Global Taurine Revenue of Manufacturers (2021-2026)
- 3.4 Global Taurine Average Price by Manufacturers (2021-2026)
- 3.5 Global Taurine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Taurine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Taurine, Product Type & Application
- 3.8 Global Manufacturers of Taurine, Established Date
- 3.9 Global Taurine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yongan Pharmaceutical
- 4.1.1 Yongan Pharmaceutical Company Information
- 4.1.2 Yongan Pharmaceutical Business Overview
- 4.1.3 Yongan Pharmaceutical Taurine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yongan Pharmaceutical Taurine Product Portfolio
- 4.1.5 Yongan Pharmaceutical Recent Developments
- 4.2 Grand Pharma
- 4.2.1 Grand Pharma Company Information
- 4.2.2 Grand Pharma Business Overview
- 4.2.3 Grand Pharma Taurine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Grand Pharma Taurine Product Portfolio
- 4.2.5 Grand Pharma Recent Developments
- 4.3 Jiangyin Huachang
- 4.3.1 Jiangyin Huachang Company Information
- 4.3.2 Jiangyin Huachang Business Overview
- 4.3.3 Jiangyin Huachang Taurine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangyin Huachang Taurine Product Portfolio
- 4.3.5 Jiangyin Huachang Recent Developments
- 4.4 Yuanyang Pharmaceutical
- 4.4.1 Yuanyang Pharmaceutical Company Information
- 4.4.2 Yuanyang Pharmaceutical Business Overview
- 4.4.3 Yuanyang Pharmaceutical Taurine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Yuanyang Pharmaceutical Taurine Product Portfolio
- 4.4.5 Yuanyang Pharmaceutical Recent Developments
- 4.5 Taisho Pharmaceutical
- 4.5.1 Taisho Pharmaceutical Company Information
- 4.5.2 Taisho Pharmaceutical Business Overview
- 4.5.3 Taisho Pharmaceutical Taurine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Taisho Pharmaceutical Taurine Product Portfolio
- 4.5.5 Taisho Pharmaceutical Recent Developments
5 Global Taurine Market Scenario by Region
- 5.1 Global Taurine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Taurine Sales by Region: 2021-2032
- 5.2.1 Global Taurine Sales by Region: 2021-2026
- 5.2.2 Global Taurine Sales by Region: 2027-2032
- 5.3 Global Taurine Revenue by Region: 2021-2032
- 5.3.1 Global Taurine Revenue by Region: 2021-2026
- 5.3.2 Global Taurine Revenue by Region: 2027-2032
- 5.4 North America Taurine Market Facts & Figures by Country
- 5.4.1 North America Taurine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Taurine Sales by Country (2021-2032)
- 5.4.3 North America Taurine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Taurine Market Facts & Figures by Country
- 5.5.1 Europe Taurine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Taurine Sales by Country (2021-2032)
- 5.5.3 Europe Taurine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Taurine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Taurine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Taurine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Taurine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Taurine Market Facts & Figures by Country
- 5.7.1 South America Taurine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Taurine Sales by Country (2021-2032)
- 5.7.3 South America Taurine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Taurine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Taurine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Taurine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Taurine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Technology
- 6.1 Global Taurine Sales by Technology (2021-2032)
- 6.1.1 Global Taurine Sales by Technology (2021-2032) & (MT)
- 6.1.2 Global Taurine Sales Market Share by Technology (2021-2032)
- 6.2 Global Taurine Revenue by Technology (2021-2032)
- 6.2.1 Global Taurine Sales by Technology (2021-2032) & (US$ Million)
- 6.2.2 Global Taurine Revenue Market Share by Technology (2021-2032)
- 6.3 Global Taurine Price by Technology (2021-2032)
7 Segment by Application
- 7.1 Global Taurine Sales by Application (2021-2032)
- 7.1.1 Global Taurine Sales by Application (2021-2032) & (MT)
- 7.1.2 Global Taurine Sales Market Share by Application (2021-2032)
- 7.2 Global Taurine Revenue by Application (2021-2032)
- 7.2.1 Global Taurine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Taurine Revenue Market Share by Application (2021-2032)
- 7.3 Global Taurine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Taurine Value Chain Analysis
- 8.1.1 Taurine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Taurine Production Mode & Process
- 8.2 Taurine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Taurine Distributors
- 8.2.3 Taurine Customers
9 Global Taurine Analyzing Market Dynamics
- 9.1 Taurine Industry Trends
- 9.2 Taurine Industry Drivers
- 9.3 Taurine Industry Opportunities and Challenges
- 9.4 Taurine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst